Kindred Bio: Q1 Earnings Snapshot
Posted May 11, 2021 1:17 pm.
Last Updated May 11, 2021 1:34 pm.
BURLINGAME, Calif. (AP) _ Kindred Biosciences Inc. (KIN) on Tuesday reported a loss of $9.7 million in its first quarter.
The Burlingame, California-based company said it had a loss of 24 cents per share.
The biopharmaceutical company posted revenue of $2.4 million in the period.
In the final minutes of trading on Tuesday, the company’s shares hit $4.43. A year ago, they were trading at $4.90.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on KIN at https://www.zacks.com/ap/KIN
The Associated Press